CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Ajanta Pharma USA Inc recalls Fenofibrate Capsules

Read the official FDA notice

Published
1 Jul 2026
Units affected
3648 bottles
Agency
FDA
Country
United States

The hazard

CGMP Deviations

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

Brand / company
Ajanta Pharma USA Inc
Codes / lots
Lot # PA02216; Exp. 12/2029
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 1 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.